Welcome to our dedicated page for AIRGAIN SEC filings (Ticker: AIRG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AIRGAIN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AIRGAIN's regulatory disclosures and financial reporting.
AIRGAIN INC President and CEO Jacob Suen reported open-market sales of 38,314 shares of Common Stock. He sold 37,314 shares at a weighted-average price of $4.1192 on March 20 and 1,000 shares at $5.00 on March 23. Footnotes explain that a portion of the shares were automatically sold to cover tax withholding tied to vesting restricted stock units through a “sell to cover” arrangement, and the transactions were executed under a pre-arranged Rule 10b5-1 trading plan. Following these sales, Suen directly holds 283,431 shares, a figure that includes RSUs.
Airgain Inc.’s Chief Technology Officer Ali Sadri reported routine insider sales tied to tax withholding. He sold a total of 14,638 shares of common stock in open‑market transactions on March 20 and March 23, 2026, at prices between about $4.12 and $5.00 per share. The filing explains these sales were executed to cover tax obligations from vesting and settlement of restricted stock units through an automatic “sell to cover” arrangement, rather than discretionary trading. The transactions were carried out under a pre‑established Rule 10b5‑1 trading plan. After these sales, Sadri directly holds 125,263 shares of Airgain common stock, which the filing notes includes RSUs.
Jacob Suen reported proposed sales of Common Stock on a Form 144. The filing lists prior restricted stock units of 1,000 granted 03/01/2021 and discloses multiple 10b5-1 sales dated 01/20/2026, 02/09/2026, 02/10/2026, and 03/04/2026 with the share counts shown in the filing.
The filing provides per‑trade share counts and gross proceeds for each trade but does not state company proceeds or any changes to outstanding capital.
AIRG filed a Form 144 reporting proposed and recent transactions in its Common Stock. The notice lists three dispositions by Ali S. Sadri totaling 3,000 shares sold across 02/09/2026, 02/10/2026, and 02/17/2026 with proceeds of $10,615.13, $4,618.71, and $5,277.39 respectively. The filing also lists 1000 shares associated with restricted stock vesting dated 03/15/2025 and a brokerage entry showing 1000 shares at Fidelity Brokerage Services LLC.
Three investors have filed a Schedule 13D on Airgain, Inc., disclosing an aggregate holding of 960,375 common shares, or 7.9% of the company. The group consists of Timothy O'Connell, Haluk L. Bayraktar and Emre Aciksoz, who purchased these shares for approximately $4,636,451.
They state they bought the stock because they view it as materially undervalued and criticize the Board for what they describe as highly ineffective creation of sustainable shareholder value since the 2016 IPO. They note the share price is more than 50% below the $8.00 IPO price, with no dividends paid.
The investors believe Airgain would be worth more to a strategic acquirer and estimate shareholders could receive about $11–$13 per share in a sale. Their estimate is based on forecast $56 million fiscal 2026 sales, roughly 44% gross margins, a two-times revenue multiple for the core antenna business and at least $25 million for the Lighthouse product. They intend to engage management and the Board and may seek to replace directors to pursue a sale or other value-maximizing transaction.
AIRGAIN INC Chief Financial Officer Michael Elbaz reported equity compensation awards. He received a stock option for 60,447 shares of common stock at an exercise price of $4.02 per share, expiring on March 14, 2036. The option vests 25% on March 15, 2027, with the remainder vesting in equal monthly installments over the following three years, subject to continued service and potential acceleration under his employment agreement.
Elbaz also acquired 10,774 fully vested restricted stock units and 9,669 restricted stock units that vest in substantially equal installments on each of March 15, 2027, March 15, 2028, March 15, 2029, and March 15, 2030, also subject to continued service and possible acceleration. Following these grants, he directly holds 153,549 shares of common stock. These awards are compensation-related acquisitions, not open-market purchases or sales.
Airgain Inc. Chief Technology Officer Ali Sadri reported equity compensation awards rather than open-market trades. He received a stock option for 43,656 shares of common stock at an exercise price of $4.02 per share, expiring in 2036, alongside new restricted stock unit grants.
The filing shows 11,116 restricted stock units that are fully vested and 6,983 restricted stock units scheduled to vest in substantially equal installments on March 15 of 2027, 2028, 2029, and 2030, subject to continued service and potential acceleration under his employment agreement.
After these awards, Sadri directly holds 139,901 shares of common stock and 43,656 option shares. These transactions are classified as grant or award acquisitions, reflecting compensation-related equity rather than discretionary buying or selling.
Airgain Inc. President and CEO Jacob Suen reported equity compensation awards on this Form 4. He received a stock option covering 82,275 shares of common stock at an exercise price of $4.0200 per share, expiring on March 14, 2036, which vests 25% on March 15, 2027 and then in equal monthly installments thereafter, subject to continued service.
He was also granted restricted stock units representing 25,653 and 13,161 shares of common stock, described as grants/awards. Footnotes state that some restricted stock units are fully vested and others vest in substantially equal installments on each of March 15, 2027, March 15, 2028, March 15, 2029 and March 15, 2030, with potential acceleration under his employment agreement. Following these grants, Suen directly holds 321,745 shares of common stock.
Airgain Inc Chief Technology Officer Ali Sadri reported an automatic sale of 1,228 shares of common stock at an average price of $4.1577 per share. The transaction was a “sell to cover” sale executed to satisfy tax withholding obligations upon vesting of restricted stock units, under a pre-existing Rule 10b5-1 instruction letter. After this non-discretionary sale, Sadri directly holds 121,802 shares, which include RSUs.
AIRGAIN INC President and CEO Jacob Suen reported an open-market sale of 3,704 shares of common stock at an average price of $4.1577 per share. According to the disclosure, this sale was executed solely to cover tax withholding obligations from the vesting and settlement of restricted stock units through an automatic “sell-to-cover” instruction under Rule 10b5-1 and is not a discretionary trade. After this transaction, Suen directly owns 282,931 shares of AIRGAIN INC common stock, which includes RSUs.